Artivion Q4 revenue $116M (+19%), GAAP net income $2.4M; full year $441M

ARTIVION, INC.

2025-FY EPS reported $0.21 revenue$441,330,000

GAAP revenue Q4 $116.0M vs $97.3M, net income $2.4M ($0.05 diluted EPS) vs net loss $16.5M in Q4 2024.
Adjusted revenue (ex Italian reserve) $118.3M, up 18% constant currency; adjusted EBITDA $22.7M (+29%).
Full year 2025 GAAP revenue $441.3M vs $388.5M; GAAP net income $9.8M vs loss $13.4M.
Filed final PMA module for AMDS Hybrid Prosthesis with FDA; positive NEXUS TRIOMPHE clinical data at STS meeting.
Non-GAAP net income Q4 $8.6M ($0.17 per share); full year $29.7M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.